NEW BRUNSWICK, N.J., Oct. 9 /PRNewswire-FirstCall/ -- Johnson & Johnson
today announced that Sheri McCoy, currently Worldwide Chairman, Surgical
Care Group, has been appointed Worldwide Chairman, Pharmaceuticals Group,
effective January 1, 2009. In this role, Ms. McCoy succeeds Christine Poon,
who last month announced plans to retire from the Company on March 1, 2009.
Alex Gorsky, currently Company Group Chairman and Worldwide Franchise
Chairman, Ethicon, Inc., will assume the role of Worldwide Chairman,
Surgical Care Group, effective January 1, 2009, and become a member of the
Executive Committee.
"Sheri and Alex are proven leaders in driving high performance and
developing talent across multiple business segments," said Johnson &
Johnson Chairman and Chief Executive Officer William C. Weldon. "These
appointments allow for a smooth transition of responsibilities within our
senior leadership team."
In being appointed earlier this year to the newly created position of
Worldwide Chairman, Surgical Care Group, Ms. McCoy's responsibilities
included the surgical franchises Ethicon, Ethicon Endo-Surgery and DePuy,
as well as medical devices and diagnostics organizations in the Latin
America, Europe/Middle East/Africa and Asia Pacific regions. She also
became a member of the Executive Committee.
Ms. McCoy, 49, joined Johnson & Johnson in 1982 as an associate
scientist in Research and Development at what was then the Personal
Products Company, and held positions of increasing responsibility within
the R&D organization. She was named Global President of the Baby and Wound
Care franchises in 2002 and held that role until 2005, when she was named
Company Group Chairman and Worldwide Franchise Chairman for Ethicon and the
Medical Devices & Diagnostics business in Latin America.
"Sheri's strong research background and breadth of experience have
prepared her well to assume the leadership of our Pharmaceuticals Group,"
Weldon said.
Mr. Gorsky, 48, joined Ethicon early this year as Company Group
Chairman and Worldwide Franchise Chairman. Until 2004, he was Company Group
Chairman for Johnson & Johnson's pharmaceuticals business in EMEA. Earlier,
he served as President of Janssen Pharmaceutica Inc. in the United States
after spending 15 years in various sales, marketing and management roles.
In 2004, Mr. Gorsky joined the Novartis Pharmaceuticals Corporation and was
head of the North American pharmaceuticals business.
Weldon said, "Throughout a long career at Johnson & Johnson, Alex has
demonstrated success in both the pharmaceutical and surgical care aspects
of our business."
About Johnson & Johnson
Caring for the world, one person at a time ... inspires and unites the
people of Johnson & Johnson. We embrace research and science -- bringing
innovative ideas, products and services to advance the health and
well-being of people. Our 120,200 employees at more than 250 Johnson &
Johnson companies work with partners in health care to touch the lives of
over a billion people every day, throughout the world.
SOURCE Johnson & Johnson
 back to top
Related links:
http://www.jnj.com
CONTACT:
Media, Bill Price, +1-732-524-6623, or
Jeffrey J. Leebaw, +1-732-524-3350, or Investors, Louise
Mehrotra, +1-732-524-6491, or Lesley Fishman, +1-732-524-3922, or
Stan Panasewicz, +1-732-524-2524, or Tina Pinto, +1-732-524-2034,
all of Johnson & Johnson
|
